Log in

Ergebnisse der ProtecT-Studie

Lokales PCa: 10-Jahres-Letalität, Progressrisiko und Therapienebenwirkungen

  • Journal club
  • Published:
InFo Hämatologie + Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Literatur

  1. Hamdy FC et al. N Engl J Med. 2016;375(15):1415-24

  2. Neal DE al. Eur Urol. 2020(3):320-30

  3. Hartman HE, Jackson WC. Cancer J. 2020;26(1):48-52

  4. Siddiqui MM et al. JAMA. 2015;313(4):390-7

  5. Cohen MS et al. Eur Urol. 2008;54(2):371-81

  6. Sun Y et al. Australas Phys Eng Sci Med. 2019;42(1):3-25

  7. Zamboglou C et al. Eur J Nucl Med Mol Imaging. 2021;48(6):1987-97

  8. Barocas DA et al. JAMA. 2017;317(11):1126-40

  9. Krauss DJ et al. Int J Radiat Oncol Biol Phys. 2017;97(1):98-106

  10. Dearnaley D et al. Lancet Oncol. 2016;17(8):1047-60

  11. Kishan AU et al. JAMA Netw Open. 2019;2(2):e188006

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Spohn, S., Grosu, AL. Lokales PCa: 10-Jahres-Letalität, Progressrisiko und Therapienebenwirkungen. InFo Hämatol Onkol 24, 37–41 (2021). https://doi.org/10.1007/s15004-021-8812-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-021-8812-6

Navigation